Abstract
Androgen insensitivity syndrome (AIS) is characterized by deficient or absent virilization in 46,XY individuals despite normal or even elevated androgen levels. AIS is usually caused by mutations in the androgen receptor (AR) gene. We aimed at contrasting clinical, biochemical, and molecular genetic characteristics of three patients (P1–P3) with clinically evident partial (P1) and complete (P2, P3) AIS with and without AR gene mutations. AR expression was studied in cultured genital skin fibroblasts (GSF) by Western immunoblotting, ligand binding analyses, Northern blotting, semiquantitative reverse transcription–polymerase chain reaction (RT-PCR), and RT-PCR spanning exons 1–8. AR gene DNA sequence was analyzed by single-strand conformation analysis (SSCA), and DNA sequencing. GSF revealed reduced (P1) or absent (P2, P3) ligand binding. Northern blots showed either slightly reduced hybridization of the 10.5-kb AR transcript (P3) or no hybridization (P1, P2), as confirmed by semiquantitative RT-PCR. RT-PCR spanning exons 1–8 detected single AR mRNA bands in P1–P3 excluding splicing errors. Western analyses showed either low (P1) or no (P2, P3) AR protein. While SSCA initially did not reveal any molecular abnormality, sequencing showed a novel CAG (Gln) to TAG (stop) mutation at codon 59 (P3) and a previously described 2-bp deletion at codon 472, leading to a frameshift and premature stop in codon 499 (P2). Intriguingly, P1 showed an unaltered DNA sequence of the coding region of the AR gene including all intron–exon boundaries. In conclusion, patients with clinically evident complete AIS are likely to harbor an AR gene mutation, demanding that the two polymorphic regions must always be included in molecular analyses of the AR gene. Moreover, our data support the concept that in a subset of AIS patients, particularly those with partial AIS, molecular alterations outside the coding region of the AR gene must be presumed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Hiort O, Holterhus PM (2000) The molecular basis of male sexual differentiation. Eur J Endocrinol 142:101–110
Holterhus PM, Hiort O, Demeter J, Brown PO, Brooks JD (2003) Differential gene-expression patterns in genital fibroblasts of normal males and 46,XY females with androgen insensitivity syndrome: evidence for early programming involving the androgen receptor. Genome Biol 4:R37.1–R37.10
Hiort O, Holterhus PM, Nitsche EM (1998) Physiology and pathophysiology of androgen action. Baillieres Clin Endocrinol Metab 12:115–132
Quigley CA, De Bellis A, Marschke KB, el-Awady MK, Wilson EM, French FS (1995) Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev 16:271–321
Marcelli M, Tilley WD, Zoppi S, Griffin JE, Wilson JD, McPhaul MJ (1991) Androgen resistance associated with a mutation of the androgen receptor at amino acid 772 (Arg-Cys) results from a combination of decreased messenger ribonucleic acid levels and impairment of receptor function. J Clin Endocrinol Metab 73:318–325
Holterhus PM, Sinnecker GH, Hiort O (2000) Phenotypic diversity and testosterone-induced normalization of mutant L712F androgen receptor function in a kindred with androgen insensitivity. J Clin Endocrinol Metab 85:3245–3250
Quigley CA, Friedman KJ, Johnson A, Lafreniere RG, Silverman LM, Lubahn DB, Brown TR, Wilson EM, Willard HF, French FS (1992) Complete deletion of the androgen receptor gene: definition of the null phenotype of the androgen insensitivity syndrome and determination of carrier status. J Clin Endocrinol Metab 74:927–933
Quigley CA, Evans BA, Simental JA, Marschke KB, Sar M, Lubahn DB, Davies P, Hughes IA, Wilson EM, French FS (1992) Complete androgen insensitivity due to deletion of exon C of the androgen receptor gene highlights the functional importance of the second zinc finger of the androgen receptor in vivo. Mol Endocrinol 6:1103–1112
Holterhus PM, Brüggenwirth HT, Hiort O, Kleinkauf-Houcken A, Kruse K, Sinnecker GH, Brinkmann AO (1997) Mosaicism due to a somatic mutation of the androgen receptor gene determines phenotype in androgen insensitivity syndrome. J Clin Endocrinol Metab 82:3584–3589
Ris-Stalpers C, Verleun-Mooijman MC, de Blaeij TJ, Degenhart HJ, Trapman J, Brinkmann AO (1994) Differential splicing of human androgen receptor pre-mRNA in X-linked Reifenstein syndrome, because of a deletion involving a putative branch site. Am J Hum Genet 54:609–617
Hellwinkel OJ, Bull K, Holterhus PM, Homburg N, Struve D, Hiort O (1999) Complete androgen insensitivity caused by a splice donor site mutation in intron 2 of the human androgen receptor gene resulting in an exon 2-lacking transcript with premature stop-codon and reduced expression. J Steroid Biochem Mol Biol 68:1–9
Hellwinkel OJ, Holterhus PM, Struve D, Marschke C, Homburg N, Hiort O (2001) A unique exonic splicing mutation in the human androgen receptor gene indicates a physiologic relevance of regular androgen receptor transcript variants. J Clin Endocrinol Metab 86:2569–2575
Choong CS, Quigley CA, French FS, Wilson EM (1996) A novel missense mutation in the amino-terminal domain of the human androgen receptor gene in a family with partial androgen insensitivity syndrome causes reduced efficiency of protein translation. J Clin Invest 98:1423–1431
Avila DM, Wilson CM, Nandi N, Griffin JE, McPhaul MJ (2002) Immunoreactive AR and genetic alterations in subjects with androgen resistance and undetectable AR levels in genital skin fibroblast ligand-binding assays. J Clin Endocrinol Metab 87:182–188
Adachi M, Takayanagi R, Tomura A, Imasaki K, Kato S, Goto K, Yanase T, Ikuyama S, Nawata H (2000) Androgen-insensitivity syndrome as a possible coactivator disease. N Engl J Med 343:856–862
Sinnecker GH, Hiort O, Nitsche EM, Holterhus PM, Kruse K, German Collaborative Intersex Study Group (1997) Functional assessment and clinical classification of androgen sensitivity in patients with mutations of the androgen receptor gene. Eur J Pediatr 156:7–14
Sambrook J, Russel DW (2001) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, New York
Brinkmann AO, Faber PW, van Rooij HC, Kuiper GG, Ris C, Klaassen P, van der Korput MM, Voorhorst JH, van Laar E, Mulder J, Trapman J (1989) The human androgen receptor: domain structure, genomic organization and regulation of expression. J Steroid Biochem 34:307–310
Hiort O, Wodtke A, Struve D, Zollner A, Sinnecker GH, German Collaborative Intersex Study Group (1994) Detection of point mutations in the androgen receptor gene using non-isotopic single strand conformation polymorphism analysis. Hum Mol Genet 3:1163–1166
Hiort O, Holterhus PM, Horter T, Schulze W, Kremke B, Bals-Pratsch M, Sinnecker GH, Kruse K (2000) Significance of mutations in the androgen receptor gene in males with idiopathic infertility. J Clin Endocrinol Metab 85:2810–2815
Lubahn DB, Brown TR, Simental JA, Higgs HN, Migeon CJ, Wilson EM, French FS (1989) Sequence of the intron/exon junctions of the coding region of the human androgen receptor gene and identification of a point mutation in a family with complete androgen insensitivity. Proc Natl Acad Sci U S A 86:9534–9538
Thiele B, Weidemann W, Schnabel D, Romalo G, Schweikert HU, Spindler KD (1999) Complete androgen insensitivity caused by a new frameshift deletion of two base pairs in exon 1 of the human androgen receptor gene. J Clin Endocrinol Metab 84:1751–1753
Zoppi S, Wilson CM, Harbison MD, Griffin JE, Wilson JD, McPhaul MJ, Marcelli M (1993) Complete testicular feminization caused by an amino-terminal truncation of the androgen receptor with downstream initiation. J Clin Invest 91:1105–1112
Imai A, Ohno T, Iida K, Ohsuye K, Okano Y, Tamaya T (1995) A frame-shift mutation of the androgen receptor gene in a patient with receptor-negative complete testicular feminization: comparison with a single base substitution in a receptor-reduced incomplete form. Ann Clin Biochem 32:482–486
Hayashi K, Yandell DW (1993) How sensitive is PCR-SSCP? Hum Mutat 2:338–346
Glavac D, Dean M (1993) Optimization of the single-strand conformation polymorphism (SSCP) technique for detection of point mutations. Hum Mutat 2:404–414
Kinoshita H, Shi Y, Sandefur C, Meisner LF, Chang C, Choon A, Reznikoff CR, Bova GS, Friedl A, Jarrard D (2000) Methylation of the androgen receptor minimal promoter silences transcription in human prostate cancer. Cancer Res 60:3623–3630
Lower KM, Kumar R, Woollatt E, Villard L, Gecz J, Sutherland GR, Callen DF (2004) Partial androgen insensitivity syndrome and t(X;5): are there upstream regulatory elements of the androgen receptor gene? Horm Res 62:208–214
Acknowledgements
The authors wish to thank C. Marschke, C. Havel, N. Homburg, and D. Struve for excellent technical assistance. This study was funded by the Deutsche Forschungsgemeinschaft (DFG) grant KFO-111/1-1 and 1-2 to P.M.H and O.H.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Holterhus, P.M., Werner, R., Hoppe, U. et al. Molecular features and clinical phenotypes in androgen insensitivity syndrome in the absence and presence of androgen receptor gene mutations. J Mol Med 83, 1005–1013 (2005). https://doi.org/10.1007/s00109-005-0704-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00109-005-0704-y